Improving the Quality of Prenatal Care for Low-Income, Black Women
提高低收入黑人女性的产前护理质量
基本信息
- 批准号:10557518
- 负责人:
- 金额:$ 24.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-11 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdherenceAdoptionAmerican College of Obstetricians and GynecologistsAreaAspirinBirthBlack raceBlood PressureBlood Pressure MonitorsCaringCessation of lifeChild CareChronicClinicClinicalComputer softwareCounselingDataDoseEducationEffectivenessEquityEvidence based programEvidence based treatmentFeedbackGeographyGoalsGuidelinesHealthHealth behaviorHigh Risk WomanHybridsHypertensionIncidenceIncomeIndividualInsuranceIntentionInterventionLow incomeMaintenanceMaternal HealthMaternal Health ServicesMaternal MortalityModelingMonitorOutcomePatient Self-ReportPatientsPerceptionPersonsPopulations at RiskPractical Robust Implementation and Sustainability ModelPre-EclampsiaPregnancyPregnant WomenPrenatal carePreventionPrevention trialProcessProteinuriaProviderRandomizedRecommendationRecording of previous eventsReduce health disparitiesReproductionResearchResearch DesignRiskRisk FactorsRuralSelf CareServicesSiteTelemedicineTimeTransportationUnderserved PopulationUninsuredVisitWomanWorkacceptability and feasibilitybarrier to careblack patientblack womenblood pressure elevationcostdesignearly onseteffectiveness evaluationempowermentevidence basehealth care disparityhealth disparityhypertension controlimplementation barriersimplementation evaluationimplementation measuresimplementation outcomesimplementation scienceimprovedinnovationmedically underservedmedication compliancemetropolitannovelpatient-level barrierspilot testpregnancy disorderpregnancy healthpreventpreventable deathprogramsprovider-level barriersracial disparityrecruittelehealthtreatment as usualtreatment disparitytrendunderserved area
项目摘要
PROJECT SUMMARY/ABSTRACT: PROJECT 5 (SMITH)
Background: The U.S. has the highest rate of maternal deaths in the developed world and over 60% of
maternal deaths in the U.S. are preventable. Preeclampsia, a disorder of pregnancy characterized by
hypertension and proteinuria, is a top preventable cause of maternal death and an important driver of health
disparities in the U.S. Chronic hypertension, a major risk factor for preeclampsia, is estimated to be present in
3% to 5% of all pregnancies but is 60% more prevalent in Black women. Black women carry a 3- to 4-fold
greater risk, compared to Whites, of dying from preeclampsia. Research suggest that women at high-risk for
preeclampsia recieve 81 to 150 mg of aspirin and counseling on and self-monitor their high blood pressure
between 11-16 until 36 weeks of gestation. The brief duration of typical prenatal visits (10 minutes on average)
hinders the provider’s ability to deliver evidence-based preeclampsia education and counseling. To date,
current research does not, moreover, take advantage of innovative and evidence-based models of prenatal
care and hypertension control that have proven feasible for providers and patients. Thus, there is a critical
need to implement and deliver guideline-consistent preeclampsia prevention in a sustainable model that
removes barriers to care for at-risk Black women. Study Design: The long-term goal of this project is to reduce
needless preeclampsia and preeclampsia-related deaths among Black pregnant women by increasing access
to evidence-based care. The objective of this study is to refine and pilot test a novel intervention that is
designed to address patient and provider barriers to preeclampsia prevention. The intervention, Centering HER
(Health, Empowerment, and Reproduction), combines a well-established and effective group prenatal care
model—Centering Pregnancy—with a promising telemedicine-based hypertension control program—Take
Control of Your Blood Pressure. To meet our study objective, the study proposes the following specific aims: 1)
To gain end-user input on the feasibility and acceptability of Centering HER, 2) To pilot the revised Centering
HER and collect feasibility and intermediate outcome data, and 3) To determine the effectiveness of Centering
HER to improve blood pressure monitoring, aspirin adherence, and implementation measures. Potential
Impact: The successful completion of the aims will be important to address the cornerstones of preeclampsia
prevention –prenatal care, medication adherence, and blood pressure monitoring and reduce maternal health
disparities. If efficacious, Centering HER may be a low cost, sustainable, translatable option ot prevent
preeclampsia in at-risk populations.
项目总结/摘要:项目5(SMITH)
背景:美国是发达国家中孕产妇死亡率最高的国家,
美国的孕产妇死亡是可以预防的。先兆子痫,一种妊娠期疾病,
高血压和蛋白尿是孕产妇死亡的首要可预防原因,也是健康的重要驱动因素
慢性高血压是先兆子痫的主要危险因素,据估计,
3%至5%的怀孕,但在黑人妇女中的患病率要高出60%。黑人女性携带3到4倍的
与白人相比,死于先兆子痫的风险更大。研究表明,高风险的女性
先兆子痫患者接受81至150毫克的阿司匹林和咨询,并自我监测他们的高血压
怀孕11-16周直到36周。典型的产前检查时间较短(平均10分钟)
阻碍了提供者提供基于证据的先兆子痫教育和咨询的能力。到目前为止,
此外,目前的研究并没有利用产前检查的创新和循证模型,
护理和高血压控制,已被证明是可行的供应商和病人。因此,有一个关键的
需要以可持续的模式实施和提供符合指南的先兆子痫预防,
消除了照顾处于危险中的黑人妇女的障碍。研究设计:本项目的长期目标是减少
通过增加获得机会,
以证据为基础的护理。本研究的目的是完善和试点测试一种新的干预措施,
旨在解决患者和提供者预防先兆子痫的障碍。干预,集中她
(健康、赋权和生殖),结合了完善和有效的团体产前护理
模式-以妊娠为中心-以一个有前途的远程医疗为基础的高血压控制计划-采取
控制你的血压。为达致研究目的,本研究提出以下具体目标:
收集最终使用者对集中式医疗卫生服务的可行性和可接受性的意见,2)试行经修订的集中式医疗卫生服务
HER并收集可行性和中间结果数据,以及3)确定定心的有效性
HER改善血压监测、阿司匹林依从性和实施措施。潜在
影响:目标的成功完成对于解决先兆子痫的基石非常重要
预防-产前护理、坚持服药和血压监测,减少孕产妇健康
差距。如果有效,集中HER可能是一种低成本,可持续,可转化的预防选择
先兆子痫的危险人群。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sharla Annette Smith其他文献
Sharla Annette Smith的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sharla Annette Smith', 18)}}的其他基金
Improving the Quality of Prenatal Care for Low-Income, Urban, Black Women
提高低收入城市黑人妇女的产前护理质量
- 批准号:
10308472 - 财政年份:2019
- 资助金额:
$ 24.24万 - 项目类别:
Improving the Quality of Prenatal Care for Low-Income, Urban, Black Women
提高低收入城市黑人妇女的产前护理质量
- 批准号:
10539277 - 财政年份:2019
- 资助金额:
$ 24.24万 - 项目类别:
Improving the Quality of Prenatal Care for Low-Income, Urban, Black Women
提高低收入城市黑人妇女的产前护理质量
- 批准号:
10065518 - 财政年份:2019
- 资助金额:
$ 24.24万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 24.24万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 24.24万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 24.24万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 24.24万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 24.24万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 24.24万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 24.24万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 24.24万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 24.24万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 24.24万 - 项目类别:
Fellowship Programs